A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults

被引：8
|
作者：
Zhang, Xiaomei [1 ]
Lv, Hairong [2 ]
Xiao, Xia [2 ]
Bai, Xue [2 ]
Liu, Pengjiang [2 ]
Pu, Yedi [2 ]
Meng, Juanxia [2 ]
Zhu, Haibo [2 ]
Wang, Zhao [2 ]
Zhang, Huan [2 ]
Zhang, Yu [2 ]
Lv, Cuicui [2 ]
Ma, Li [2 ]
Yuan, Ting [2 ]
Zhang, Meng [2 ]
Sun, Rui [1 ]
Zhao, Yifan [2 ]
Cao, Xinping [2 ]
Guo, Ruiting [2 ]
Zhang, Yi [2 ]
Guo, Shujing [2 ]
Liu, Jile [2 ]
Zhao, Mingfeng [1 ,2 ]
机构：
[1] Nankai Univ, Med Sch, Tianjin, Peoples R China
[2] Tianjin First Cent Hosp, Tianjin, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180387
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Jin, Xin
    Zhang, Meng
    Sun, Rui
    Lyu, Hairong
    Xiao, Xia
    Zhang, Xiaomei
    Li, Fan
    Xie, Danni
    Xiong, Xia
    Wang, Jiaxi
    Lu, Wenyi
    Zhang, Hongkai
    Zhao, Mingfeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [2] First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
    Xin Jin
    Meng Zhang
    Rui Sun
    Hairong Lyu
    Xia Xiao
    Xiaomei Zhang
    Fan Li
    Danni Xie
    Xia Xiong
    Jiaxi Wang
    Wenyi Lu
    Hongkai Zhang
    Mingfeng Zhao
    Journal of Hematology & Oncology, 15
  • [3] Phase I Clinical Trial of Autologous CLL1 CAR-T Therapy for Pediatric Patients with Relapsed and Refractory Acute Myeloid Leukemia
    Bu, Chaoke
    Peng, Zhiyong
    Luo, Min
    Li, Guangchao
    Li, Chunfu
    BLOOD, 2020, 136
  • [4] CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
    Jinghua Wang
    Siyu Chen
    Wei Xiao
    Wende Li
    Liang Wang
    Shuo Yang
    Weida Wang
    Liping Xu
    Shuangye Liao
    Wenjian Liu
    Yang Wang
    Nawei Liu
    Jianeng Zhang
    Xiaojun Xia
    Tiebang Kang
    Gong Chen
    Xiuyu Cai
    Han Yang
    Xing Zhang
    Yue Lu
    Penghui Zhou
    Journal of Hematology & Oncology, 11
  • [5] CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
    Wang, Jinghua
    Chen, Siyu
    Xiao, Wei
    Li, Wende
    Wang, Liang
    Yang, Shuo
    Wang, Weida
    Xu, Liping
    Liao, Shuangye
    Liu, Wenjian
    Wang, Yang
    Liu, Nawei
    Zhang, Jianeng
    Xia, Xiaojun
    Kang, Tiebang
    Chen, Gong
    Cai, Xiuyu
    Yang, Han
    Zhang, Xing
    Lu, Yue
    Zhou, Penghui
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [6] Cytotoxic effect of CLL-1 CAR-T cell immunotherapy with PD-1 silencing on relapsed/refractory acute myeloid leukemia
    Lin, Guoqiang
    Zhang, Yanming
    Yu, Lei
    Wu, Depei
    MOLECULAR MEDICINE REPORTS, 2021, 23 (03)
  • [7] Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
    Zhang, Meng
    Zhang, Xiaomei
    Wang, Jiaxi
    Lu, Wenyi
    Xiao, Xia
    Lyu, Hairong
    He, Xiaoyuan
    Pu, Yedi
    Meng, Juanxia
    Lyu, Cuicui
    Cao, Xinping
    Zhao, Mingfeng
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [8] Dual CD33/CLL-1 Targeted CAR T Cells for Treatment of Acute Myeloid Leukemia
    Kowal, Kevin
    Kim, Miriam
    Ritchey, Julie
    Cooper, Matthew
    O'Neal, Julie
    Di Persio, John
    MOLECULAR THERAPY, 2022, 30 (04) : 401 - 401
  • [9] Enhancing the Effect of CLL-1 CAR T Cells with Interleukin-15 for Treatment of Acute Myeloid Leukemia
    Atilla, Pinar Ataca
    Tashiro, Haruko
    McKenna, Mary Kathryn
    Srinivasan, Madhuwanti
    Simons, Brian Wesley
    Stevens, Alexandra McLean
    Redell, Michele
    Mamonkin, Maksim
    Brenner, Malcolm K.
    Atilla, Erden
    BLOOD, 2019, 134
  • [10] CLL-1 is a potential target for the treatment of acute myeloid leukemia
    Korver, Wouter
    Zhao, Xiaoxian
    Singh, Shweta
    Hsi, Eric D.
    Abo, Arie
    BLOOD, 2007, 110 (11) : 835A - 835A
12345